Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Stadler

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cancer Research|December 20, 1999
Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17B A Yoshida, Z Dubauskas, M A Chekmareva, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Metastatic bladder cancer: advances in treatmentW M Stadler, T M Kuzel, D Raghavan, et al.
Clinical and Experimental Dermatology|July 11, 2006
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitorM E Lacouture, A Desai, K Soltani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Study of cohort-specific consent and patient control in phase I cancer trialsC K Daugherty, M J Ratain, H Minami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4B R Konety, T S Nguyen, R Dhir, et al.
The Journal of Urology|October 23, 1997
Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridizationJ E Reeder, J F Morreale, M J O'Connell, et al.
Urology|September 4, 1999
In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancerT P Beck, E J Kirsh, S J Chmura, et al.
Investigational New Drugs|October 22, 2008
MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failureR Dreicer, W M Stadler, F R Ahmann, et al.
Bone Marrow Transplantation|November 16, 2004
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago ExperienceA S Artz, K Van Besien, T Zimmerman, et al.
Prostate Cancer and Prostatic Diseases|October 19, 2011
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium studyJ E Ward, T Karrison, G Chatta, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cancer Research|December 20, 1999
Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17B A Yoshida, Z Dubauskas, M A Chekmareva, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Metastatic bladder cancer: advances in treatmentW M Stadler, T M Kuzel, D Raghavan, et al.
Clinical and Experimental Dermatology|July 11, 2006
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitorM E Lacouture, A Desai, K Soltani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Study of cohort-specific consent and patient control in phase I cancer trialsC K Daugherty, M J Ratain, H Minami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4B R Konety, T S Nguyen, R Dhir, et al.
The Journal of Urology|October 23, 1997
Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridizationJ E Reeder, J F Morreale, M J O'Connell, et al.
Urology|September 4, 1999
In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancerT P Beck, E J Kirsh, S J Chmura, et al.
Investigational New Drugs|October 22, 2008
MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failureR Dreicer, W M Stadler, F R Ahmann, et al.
Bone Marrow Transplantation|November 16, 2004
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago ExperienceA S Artz, K Van Besien, T Zimmerman, et al.
Prostate Cancer and Prostatic Diseases|October 19, 2011
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium studyJ E Ward, T Karrison, G Chatta, et al.
Pageof 7